1
/
of
0
FDA Human Factors Study Documents in Summary Basis of Approval for ANDA 215503 (LIRAGLUTIDE) Approved Dec 23, 2024
FDA Human Factors Study Documents in Summary Basis of Approval for ANDA 215503 (LIRAGLUTIDE) Approved Dec 23, 2024
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: A copy of documents in the summary basis of approval relevant to any Human Factors Studies conducted for the approval of ANDA 215503 (LIRAGLUTIDE) approved on December 23, 2024.
Tags: Pharma, ANDA, 2024
Tags: Pharma, ANDA, 2024
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details